InventisBio Co., Limited (SHA:688382)

InventisBio Statistics

Total Valuation

InventisBio has a market cap or net worth of CNY 13.00 billion. The enterprise value is 11.64 billion.

Market Cap	13.00B
Enterprise Value	11.64B

Important Dates

The last earnings date was Wednesday, April 15, 2026.

Earnings Date	Apr 15, 2026
Ex-Dividend Date	n/a

Share Statistics

InventisBio has 578.35 million shares outstanding. The number of shares has increased by 0.74% in one year.

Current Share Class	578.35M
Shares Outstanding	578.35M
Shares Change (YoY)	+0.74%
Shares Change (QoQ)	-11.13%
Owned by Insiders (%)	10.10%
Owned by Institutions (%)	38.75%
Float	397.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	181.47
PB Ratio	8.69
P/TBV Ratio	8.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-38.33
EV / Sales	162.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-48.07

Financial Position

The company has a current ratio of 17.36, with a Debt / Equity ratio of 0.01.

Current Ratio	17.36
Quick Ratio	16.94
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	-400.85

Financial Efficiency

Return on equity (ROE) is -18.60% and return on invested capital (ROIC) is -12.65%.

Return on Equity (ROE)	-18.60%
Return on Assets (ROA)	-12.04%
Return on Invested Capital (ROIC)	-12.65%
Return on Capital Employed (ROCE)	-22.14%
Weighted Average Cost of Capital (WACC)	6.43%
Revenue Per Employee	393,643
Profits Per Employee	-1.67M
Employee Count	168
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

In the past 12 months, InventisBio has paid 347,480 in taxes.

Income Tax	347,480
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.35% in the last 52 weeks. The beta is 0.40, so InventisBio's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	+7.35%
50-Day Moving Average	20.96
200-Day Moving Average	29.36
Relative Strength Index (RSI)	54.46
Average Volume (20 Days)	18,052,679

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, InventisBio had revenue of CNY 71.64 million and -303.73 million in losses. Loss per share was -0.53.

Revenue	71.64M
Gross Profit	66.15M
Operating Income	-334.76M
Pretax Income	-303.39M
Net Income	-303.73M
EBITDA	-330.08M
EBIT	-334.76M
Loss Per Share	-0.53

Balance Sheet

The company has 1.38 billion in cash and 19.97 million in debt, with a net cash position of 1.36 billion or 2.35 per share.

Cash & Cash Equivalents	1.38B
Total Debt	19.97M
Net Cash	1.36B
Net Cash Per Share	2.35
Equity (Book Value)	1.50B
Book Value Per Share	2.70
Working Capital	1.46B

Cash Flow

In the last 12 months, operating cash flow was -236.05 million and capital expenditures -6.18 million, giving a free cash flow of -242.22 million.

Operating Cash Flow	-236.05M
Capital Expenditures	-6.18M
Depreciation & Amortization	4.90M
Net Borrowing	n/a
Free Cash Flow	-242.22M
FCF Per Share	-0.42

Margins

Gross Margin	92.34%
Operating Margin	-467.26%
Pretax Margin	-423.47%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

InventisBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.74%
Shareholder Yield	-0.74%
Earnings Yield	-2.34%
FCF Yield	-1.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1